FDA NDC Directory · JSON-LD · Markdown

VIMIZIM

NDC 68135-100 · HUMAN PRESCRIPTION DRUG · INJECTION, SOLUTION, CONCENTRATE

Generic nameelosulfase alfa
Labeler / ManufacturerBioMarin Pharmaceutical Inc.
Marketing categoryBiologic License Application · App BLA125460
Dosage form / routeINJECTION, SOLUTION, CONCENTRATE · INTRAVENOUS
Active ingredientsELOSULFASE ALFA (5 mg/5mL)
Marketing started20140214
Package count1

External sources

Source: openFDA. Public-domain (CC0).